CBIZ (NYSE:CBZ) Earns Daily News Impact Rating of 0.10

Media stories about CBIZ (NYSE:CBZ) have trended somewhat positive recently, Accern reports. The research group identifies positive and negative press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. CBIZ earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave news coverage about the business services provider an impact score of 43.0724243133358 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

CBIZ (NYSE CBZ) opened at $16.55 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.54 and a current ratio of 1.54. CBIZ has a 1 year low of $12.70 and a 1 year high of $17.25. The stock has a market cap of $899.56, a price-to-earnings ratio of 20.18 and a beta of 0.79.

CBIZ (NYSE:CBZ) last released its earnings results on Thursday, November 2nd. The business services provider reported $0.18 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.22 by ($0.04). CBIZ had a net margin of 5.34% and a return on equity of 8.94%. The company had revenue of $207.70 million for the quarter, compared to analyst estimates of $212.66 million. During the same quarter in the previous year, the firm earned $0.20 EPS. The firm’s revenue was up 4.0% on a year-over-year basis. research analysts expect that CBIZ will post 0.84 earnings per share for the current fiscal year.

A number of brokerages have recently issued reports on CBZ. Zacks Investment Research upgraded shares of CBIZ from a “sell” rating to a “hold” rating in a research report on Tuesday, January 2nd. ValuEngine downgraded shares of CBIZ from a “buy” rating to a “hold” rating in a research report on Friday, December 1st.

In other CBIZ news, Director Steven L. Gerard sold 26,423 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $15.03, for a total transaction of $397,137.69. Following the completion of the sale, the director now owns 349,906 shares in the company, valued at approximately $5,259,087.18. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael P. Kouzelos sold 35,000 shares of the business’s stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $14.95, for a total transaction of $523,250.00. Following the sale, the insider now owns 287,972 shares of the company’s stock, valued at approximately $4,305,181.40. The disclosure for this sale can be found here. Insiders have sold a total of 105,053 shares of company stock valued at $1,575,512 in the last 90 days. 6.90% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: “CBIZ (NYSE:CBZ) Earns Daily News Impact Rating of 0.10” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece on another domain, it was illegally stolen and reposted in violation of United States and international copyright legislation. The original version of this piece can be accessed at https://stocknewstimes.com/2018/01/12/cbiz-cbz-earns-media-sentiment-rating-of-0-10.html.

CBIZ Company Profile

CBIZ, Inc (CBIZ) is engaged in the professional services business. The Company operates its professional services business through acquiring and integrating accounting and financial service providers, group health benefits consulting firms, property and casualty brokerage firms, payroll service providers, and valuation and other service firms throughout the United States.

Insider Buying and Selling by Quarter for CBIZ (NYSE:CBZ)

Receive News & Ratings for CBIZ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBIZ and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply